Cargando…

Adverse events from pharmacopuncture treatment in Korea: A protocol for systematic review and meta analysis

BACKGROUND: Pharmacopuncture is a combination of acupuncture and herbal medicine, which involves the injection of herbal extracts into acupuncture points (acupoints). Pharmacopuncture has become one of the major therapeutic tools used in Korea; however, safety is one of the major concerns associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jae Eun, Kang, Sohyeon, Jang, Bo-Hyoung, Shin, Yong-Cheol, Ko, Seong-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982247/
https://www.ncbi.nlm.nih.gov/pubmed/33725988
http://dx.doi.org/10.1097/MD.0000000000025107
_version_ 1783667680462503936
author Park, Jae Eun
Kang, Sohyeon
Jang, Bo-Hyoung
Shin, Yong-Cheol
Ko, Seong-Gyu
author_facet Park, Jae Eun
Kang, Sohyeon
Jang, Bo-Hyoung
Shin, Yong-Cheol
Ko, Seong-Gyu
author_sort Park, Jae Eun
collection PubMed
description BACKGROUND: Pharmacopuncture is a combination of acupuncture and herbal medicine, which involves the injection of herbal extracts into acupuncture points (acupoints). Pharmacopuncture has become one of the major therapeutic tools used in Korea; however, safety is one of the major concerns associated with it. We aim to systematically review clinical studies on the adverse events of pharmacopuncture in Korea. METHODS: To collect data on the incidence and characteristics of adverse events (AEs) and to evaluate pharmacopuncture safety, 2 or more researchers will conduct a comprehensive search of pertinent English and Korean databases using the keywords “pharmacopuncture” and “adverse events.” Regardless of the participants’ conditions or treatment types, we will include clinical studies on the AEs of pharmacopuncture. Studies that were not conducted in Korea, and acupoint injections containing Western medications, vitamins, or autologous serum will be excluded from this study. The severity of AEs will be classified using the common terminology criteria for adverse events, and the causality between pharmacopuncture and AEs will be assessed using the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) causality scale. The quality of identifying and reporting the AEs will be assessed using the McHarm scale. The risk of selection bias will be assessed using the Cochrane risk of bias and the risk of bias for non-randomized studies tools. Studies will be assessed for heterogeneity utilizing Higgins's I(2) statistics, and the risk of publication bias will be assessed and expressed in the form of a contour-enhanced funnel plot. RESULTS AND CONCLUSION: Comprehensive investigation of all types of clinical studies in Korea will provide clearer evidence of the safety of pharmacopuncture. The results of this study will be useful for traditional medical doctors and patients who use such treatments and interventions. Systematic Review Registration: Open Science Foundation (osf.io/umhyz).
format Online
Article
Text
id pubmed-7982247
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-79822472021-03-23 Adverse events from pharmacopuncture treatment in Korea: A protocol for systematic review and meta analysis Park, Jae Eun Kang, Sohyeon Jang, Bo-Hyoung Shin, Yong-Cheol Ko, Seong-Gyu Medicine (Baltimore) 3800 BACKGROUND: Pharmacopuncture is a combination of acupuncture and herbal medicine, which involves the injection of herbal extracts into acupuncture points (acupoints). Pharmacopuncture has become one of the major therapeutic tools used in Korea; however, safety is one of the major concerns associated with it. We aim to systematically review clinical studies on the adverse events of pharmacopuncture in Korea. METHODS: To collect data on the incidence and characteristics of adverse events (AEs) and to evaluate pharmacopuncture safety, 2 or more researchers will conduct a comprehensive search of pertinent English and Korean databases using the keywords “pharmacopuncture” and “adverse events.” Regardless of the participants’ conditions or treatment types, we will include clinical studies on the AEs of pharmacopuncture. Studies that were not conducted in Korea, and acupoint injections containing Western medications, vitamins, or autologous serum will be excluded from this study. The severity of AEs will be classified using the common terminology criteria for adverse events, and the causality between pharmacopuncture and AEs will be assessed using the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) causality scale. The quality of identifying and reporting the AEs will be assessed using the McHarm scale. The risk of selection bias will be assessed using the Cochrane risk of bias and the risk of bias for non-randomized studies tools. Studies will be assessed for heterogeneity utilizing Higgins's I(2) statistics, and the risk of publication bias will be assessed and expressed in the form of a contour-enhanced funnel plot. RESULTS AND CONCLUSION: Comprehensive investigation of all types of clinical studies in Korea will provide clearer evidence of the safety of pharmacopuncture. The results of this study will be useful for traditional medical doctors and patients who use such treatments and interventions. Systematic Review Registration: Open Science Foundation (osf.io/umhyz). Lippincott Williams & Wilkins 2021-03-19 /pmc/articles/PMC7982247/ /pubmed/33725988 http://dx.doi.org/10.1097/MD.0000000000025107 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Park, Jae Eun
Kang, Sohyeon
Jang, Bo-Hyoung
Shin, Yong-Cheol
Ko, Seong-Gyu
Adverse events from pharmacopuncture treatment in Korea: A protocol for systematic review and meta analysis
title Adverse events from pharmacopuncture treatment in Korea: A protocol for systematic review and meta analysis
title_full Adverse events from pharmacopuncture treatment in Korea: A protocol for systematic review and meta analysis
title_fullStr Adverse events from pharmacopuncture treatment in Korea: A protocol for systematic review and meta analysis
title_full_unstemmed Adverse events from pharmacopuncture treatment in Korea: A protocol for systematic review and meta analysis
title_short Adverse events from pharmacopuncture treatment in Korea: A protocol for systematic review and meta analysis
title_sort adverse events from pharmacopuncture treatment in korea: a protocol for systematic review and meta analysis
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982247/
https://www.ncbi.nlm.nih.gov/pubmed/33725988
http://dx.doi.org/10.1097/MD.0000000000025107
work_keys_str_mv AT parkjaeeun adverseeventsfrompharmacopuncturetreatmentinkoreaaprotocolforsystematicreviewandmetaanalysis
AT kangsohyeon adverseeventsfrompharmacopuncturetreatmentinkoreaaprotocolforsystematicreviewandmetaanalysis
AT jangbohyoung adverseeventsfrompharmacopuncturetreatmentinkoreaaprotocolforsystematicreviewandmetaanalysis
AT shinyongcheol adverseeventsfrompharmacopuncturetreatmentinkoreaaprotocolforsystematicreviewandmetaanalysis
AT koseonggyu adverseeventsfrompharmacopuncturetreatmentinkoreaaprotocolforsystematicreviewandmetaanalysis